NCT06907199View on ClinicalTrials.gov

Daily Nitrofurantoin Versus Bladder Fulguration Plus Daily Nitrofurantoin for Women With Recurrent Urinary Tract Infections

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

104

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

July 1, 2028

Study Completion Date

January 30, 2029

Conditions
Recurrent UTIsCystitis Recurrent
Interventions
PROCEDURE

Electrofulguration (EF)

Nitrofurantoin (NF) daily antibiotic prophylaxis for 6 months plus Electrofulguration.

DRUG

Nitrofurantoin (NF)

Nitrofurantoin (NF) daily antibiotic prophylaxis given daily for 6 months.

Trial Locations (2)

66160

The University of Kansas, Kansas City

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
collaborator

University of Texas

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Texas Southwestern Medical Center

OTHER